Vitamin Blue Stock Performance
| VTMB Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Vitamin Blue are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Vitamin Blue has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Vitamin Blue is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -7017.00 |
Vitamin |
Vitamin Blue Relative Risk vs. Return Landscape
If you would invest 0.01 in Vitamin Blue on January 18, 2024 and sell it today you would earn a total of 0.00 from holding Vitamin Blue or generate 0.0% return on investment over 90 days. Vitamin Blue is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Vitamin, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vitamin Blue Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vitamin Blue's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Vitamin Blue, and traders can use it to determine the average amount a Vitamin Blue's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VTMB |
Based on monthly moving average Vitamin Blue is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vitamin Blue by adding Vitamin Blue to a well-diversified portfolio.
Vitamin Blue Fundamentals Growth
Vitamin Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Vitamin Blue, and Vitamin Blue fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vitamin Pink Sheet performance.
| Return On Asset | -1.4 | |||
| Operating Margin | (0.78) % | |||
| Current Valuation | 766.89 K | |||
| Shares Outstanding | 783.4 M | |||
| Price To Earning | (0.40) X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 250.03 K | |||
| EBITDA | (112.37 K) | |||
| Cash And Equivalents | 2.52 K | |||
| Total Debt | 307.37 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | 7.69 K | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 31.72 K | |||
| Retained Earnings | (2.84 M) | |||
| Current Asset | 30 K | |||
| Current Liabilities | 736 K | |||
About Vitamin Blue Performance
To evaluate Vitamin Blue Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Vitamin Blue generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Vitamin Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Vitamin Blue market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Vitamin's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Vitamin Blue, Inc. designs, develops, produces, and distributes water boardsports apparel and related products primarily in the United States. Vitamin Blue, Inc. was founded in 1999 and is based in Costa Mesa, California. Vitamin Blue operates under Leisure classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Vitamin Blue performance evaluation
Checking the ongoing alerts about Vitamin Blue for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Vitamin Blue help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vitamin Blue generated a negative expected return over the last 90 days | |
| Vitamin Blue has some characteristics of a very speculative penny stock | |
| Vitamin Blue has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 307.37 K in liabilities. Vitamin Blue has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vitamin Blue until it has trouble settling it off, either with new capital or with free cash flow. So, Vitamin Blue's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vitamin Blue sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vitamin to invest in growth at high rates of return. When we think about Vitamin Blue's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 250.03 K. Net Loss for the year was (21.08 K) with profit before overhead, payroll, taxes, and interest of 55.5 K. |
- Analyzing Vitamin Blue's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vitamin Blue's stock is overvalued or undervalued compared to its peers.
- Examining Vitamin Blue's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vitamin Blue's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vitamin Blue's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vitamin Blue's pink sheet. These opinions can provide insight into Vitamin Blue's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vitamin Blue. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Vitamin Pink Sheet analysis
When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |